[HTML][HTML] Extracellular vesicle microRNA: A promising biomarker and therapeutic target for respiratory diseases
J Lv, X Xiong - International Journal of Molecular Sciences, 2024 - mdpi.com
Respiratory diseases, including chronic obstructive pulmonary disease (COPD), asthma,
lung cancer, and coronavirus pneumonia, present a major global health challenge. Current …
lung cancer, and coronavirus pneumonia, present a major global health challenge. Current …
A review of the scientific literature on experimental toxicity studies of COVID-19 vaccines, with special attention to publications in toxicology journals
JL Domingo - Archives of Toxicology, 2024 - Springer
Since the reports of the first cases of COVID-19, in less than 5 years, a huge number of
documents regarding that disease and the coronavirus (SARS-CoV-2), responsible for the …
documents regarding that disease and the coronavirus (SARS-CoV-2), responsible for the …
The mRNA-LNP vaccines–the good, the bad and the ugly?
BZ Igyártó, Z Qin - Frontiers in Immunology, 2024 - frontiersin.org
The mRNA-LNP vaccine has received much attention during the COVID-19 pandemic since
it served as the basis of the most widely used SARS-CoV-2 vaccines in Western countries …
it served as the basis of the most widely used SARS-CoV-2 vaccines in Western countries …
[HTML][HTML] mRNA Vaccines Against COVID-19 as Trailblazers for Other Human Infectious Diseases
R Brandi, A Paganelli, R D'Amelio, P Giuliani… - Vaccines, 2024 - pmc.ncbi.nlm.nih.gov
mRNA vaccines represent a milestone in the history of vaccinology, because they are safe,
very effective, quick and cost-effective to produce, easy to adapt should the antigen vary …
very effective, quick and cost-effective to produce, easy to adapt should the antigen vary …